Santhera Pharmaceuticals Holding AG (XSWX:SANN) Accounts Payable & Accrued Expense : CHF9.12 Mil (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Accounts Payable & Accrued Expense?

Santhera Pharmaceuticals Holding AG's quarterly accounts payable & accrued expense increased from Jun. 2022 (CHF5.32 Mil) to Dec. 2022 (CHF8.14 Mil) and increased from Dec. 2022 (CHF8.14 Mil) to Jun. 2023 (CHF9.12 Mil).

Santhera Pharmaceuticals Holding AG's annual accounts payable & accrued expense declined from Dec. 2020 (CHF5.78 Mil) to Dec. 2021 (CHF4.85 Mil) but then increased from Dec. 2021 (CHF4.85 Mil) to Dec. 2022 (CHF8.14 Mil).

Santhera Pharmaceuticals Holding AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Accounts Payable & Accrued Expense Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

9.79

11.04

5.78

4.85

8.14

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.10	4.85	5.32	8.14	9.12

Santhera Pharmaceuticals Holding AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SPHDF:USA SANNz:UK

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines